Boston Scientific (BSX) Return on Capital Employed (2009 - 2026)

Boston Scientific (BSX) has 18 years of Return on Capital Employed data on file, last reported at 9.62% in Q1 2026.

• For the quarter ending Q1 2026, Return on Capital Employed rose 141.0% year-over-year to 9.62%; the trailing twelve-month figure through Mar 2026 stood at 9.62% (up 141.0% YoY), and the FY2025 full-year result was 10.01%, up 158.0% from the prior year.
• Return on Capital Employed held at 9.62% in Q1 2026, from 9.57% in the prior quarter.
• In the past five years, Return on Capital Employed ranged from a high of 9.62% in Q1 2026 to a low of 4.62% in Q1 2022.
• A 5-year average of 7.4% and a median of 7.9% in 2023 frame the typical range for Return on Capital Employed.
• Across the five-year window, Return on Capital Employed jumped 410 bps in 2022 and grew 15 bps in 2024, its largest moves.
• Tracing BSX's Return on Capital Employed over 5 years: stood at 5.81% in 2022, then surged by 36 bps to 7.9% in 2023, then grew by 2 bps to 8.05% in 2024, then gained by 19 bps to 9.57% in 2025, then rose by 0 bps to 9.62% in 2026.
• Business Quant data shows BSX's Return on Capital Employed at 9.62% in Q1 2026, 9.57% in Q4 2025, and 9.41% in Q3 2025.